Starling Oncology director Brad Hively to step down as vice chairman, not seek re-election in 2027

Starling Oncology director Brad Hively will not stand for re-election at the 2027 annual stockholders meeting. * He will remain on the board until the meeting. * Effective immediately, Hively stepped down as vice chairman. * He also left the compliance committee, ending all committee roles. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Starling Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001079973-26-001208), on September 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here